Developer of an intra-uterine device designed to deliver pain medication instead of hormones. The company's device uses polymer-based technology that releases a low, localized dose of medication direc...

Interested in buying or selling Meliodays shares?

All transactions are brokered and confidential.

Valuation
Share Price
N/A
Total Raised
$850K
Last Round
N/A
Company Details
Sector
Healthcare
Headquarters
Munich, Germany
Founded
2022
Employees
7

Explore Meliodays's full profile

Funding history, team members, and investor details — free with an account. No credit card required.

Free access · No credit card required